433 related articles for article (PubMed ID: 12670875)
21. Regression of ocular neovascularization in response to increased expression of pigment epithelium-derived factor.
Mori K; Gehlbach P; Ando A; McVey D; Wei L; Campochiaro PA
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2428-34. PubMed ID: 12091447
[TBL] [Abstract][Full Text] [Related]
22. Differential effects of bactericidal/permeability-increasing protein (BPI) analogues on retinal neovascularization and retinal pericyte growth.
Rauniyar RK; Suzuma K; King AL; Aiello LP; King GL
Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):503-9. PubMed ID: 11818397
[TBL] [Abstract][Full Text] [Related]
23. Expression of thrombospondin-1 in ischemia-induced retinal neovascularization.
Suzuma K; Takagi H; Otani A; Oh H; Honda Y
Am J Pathol; 1999 Feb; 154(2):343-54. PubMed ID: 10027393
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularization.
Spilsbury K; Garrett KL; Shen WY; Constable IJ; Rakoczy PE
Am J Pathol; 2000 Jul; 157(1):135-44. PubMed ID: 10880384
[TBL] [Abstract][Full Text] [Related]
25. Evolution of neovascularization in mice with overexpression of vascular endothelial growth factor in photoreceptors.
Tobe T; Okamoto N; Vinores MA; Derevjanik NL; Vinores SA; Zack DJ; Campochiaro PA
Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):180-8. PubMed ID: 9430560
[TBL] [Abstract][Full Text] [Related]
26. Choroidal neovascularization in the rat induced by adenovirus mediated expression of vascular endothelial growth factor.
Baffi J; Byrnes G; Chan CC; Csaky KG
Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3582-9. PubMed ID: 11006256
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory effect of full-length human endostatin on in vitro angiogenesis.
Taddei L; Chiarugi P; Brogelli L; Cirri P; Magnelli L; Raugei G; Ziche M; Granger HJ; Chiarugi V; Ramponi G
Biochem Biophys Res Commun; 1999 Sep; 263(2):340-5. PubMed ID: 10491294
[TBL] [Abstract][Full Text] [Related]
28. The angiogenesis inhibitor endostatin impairs blood vessel maturation during wound healing.
Bloch W; Huggel K; Sasaki T; Grose R; Bugnon P; Addicks K; Timpl R; Werner S
FASEB J; 2000 Dec; 14(15):2373-6. PubMed ID: 11024009
[TBL] [Abstract][Full Text] [Related]
29. Endogenous endostatin inhibits choroidal neovascularization.
Marneros AG; She H; Zambarakji H; Hashizume H; Connolly EJ; Kim I; Gragoudas ES; Miller JW; Olsen BR
FASEB J; 2007 Dec; 21(14):3809-18. PubMed ID: 17526870
[TBL] [Abstract][Full Text] [Related]
30. Intraocular gutless adenoviral-vectored VEGF stimulates anterior segment but not retinal neovascularization.
Oshima Y; Takahashi K; Oshima S; Saishin Y; Saishin Y; Silva RL; Liang X; Reddy PS; Ganesh S; Brann T; Liau G; Kaleko M; Connelly S; Campochiaro PA
J Cell Physiol; 2004 Jun; 199(3):399-411. PubMed ID: 15095287
[TBL] [Abstract][Full Text] [Related]
31. Hyperoxia causes decreased expression of vascular endothelial growth factor and endothelial cell apoptosis in adult retina.
Yamada H; Yamada E; Hackett SF; Ozaki H; Okamoto N; Campochiaro PA
J Cell Physiol; 1999 May; 179(2):149-56. PubMed ID: 10199554
[TBL] [Abstract][Full Text] [Related]
32. Adenovirus-mediated endostatin delivery results in inhibition of mammary gland tumor growth in C3(1)/SV40 T-antigen transgenic mice.
Calvo A; Feldman AL; Libutti SK; Green JE
Cancer Res; 2002 Jul; 62(14):3934-8. PubMed ID: 12124322
[TBL] [Abstract][Full Text] [Related]
33. Reduction of experimental diabetic vascular leakage by delivery of angiostatin with a recombinant adeno-associated virus vector.
Shyong MP; Lee FL; Kuo PC; Wu AC; Cheng HC; Chen SL; Tung TH; Tsao YP
Mol Vis; 2007 Jan; 13():133-41. PubMed ID: 17293777
[TBL] [Abstract][Full Text] [Related]
34. VEGF164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularization.
Ishida S; Usui T; Yamashiro K; Kaji Y; Amano S; Ogura Y; Hida T; Oguchi Y; Ambati J; Miller JW; Gragoudas ES; Ng YS; D'Amore PA; Shima DT; Adamis AP
J Exp Med; 2003 Aug; 198(3):483-9. PubMed ID: 12900522
[TBL] [Abstract][Full Text] [Related]
35. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
Stalmans I
Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
[TBL] [Abstract][Full Text] [Related]
36. Periocular gene transfer of sFlt-1 suppresses ocular neovascularization and vascular endothelial growth factor-induced breakdown of the blood-retinal barrier.
Gehlbach P; Demetriades AM; Yamamoto S; Deering T; Xiao WH; Duh EJ; Yang HS; Lai H; Kovesdi I; Carrion M; Wei L; Campochiaro PA
Hum Gene Ther; 2003 Jan; 14(2):129-41. PubMed ID: 12614564
[TBL] [Abstract][Full Text] [Related]
37. In vivo monitoring of VEGF-induced retinal damage in the Kimba mouse model of retinal neovascularization.
Ali Rahman IS; Li CR; Lai CM; Rakoczy EP
Curr Eye Res; 2011 Jul; 36(7):654-62. PubMed ID: 21657827
[TBL] [Abstract][Full Text] [Related]
38. Quantitative MR imaging study of intravitreal sustained release of VEGF in rabbits.
Alikacem N; Yoshizawa T; Nelson KD; Wilson CA
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1561-9. PubMed ID: 10798677
[TBL] [Abstract][Full Text] [Related]
39. Celecoxib, a selective cyclooxygenase-2 inhibitor, inhibits retinal vascular endothelial growth factor expression and vascular leakage in a streptozotocin-induced diabetic rat model.
Ayalasomayajula SP; Kompella UB
Eur J Pharmacol; 2003 Jan; 458(3):283-9. PubMed ID: 12504784
[TBL] [Abstract][Full Text] [Related]
40. Systemic rapamycin inhibits retinal and choroidal neovascularization in mice.
Dejneka NS; Kuroki AM; Fosnot J; Tang W; Tolentino MJ; Bennett J
Mol Vis; 2004 Dec; 10():964-72. PubMed ID: 15623986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
